INTRODUCTION: Gastric bypass surgery (GBP) leads to sustained weight loss and significant improvement in type 2 diabetes (T2DM). Bile acids (BAs), signaling molecules which influence glucose metabolism, are a potential mediator for the improvement in T2DM after GBP. This study sought to investigate the effect of GBP on BA levels and composition in individuals with T2DM. METHODS: Plasma BA levels and composition and fibroblast growth factor (FGF)-19 levels were measured during fasting and in response to an oral glucose load before and at 1 month and 2 years post GBP in 13 severely obese women with T2DM. RESULTS: A striking temporal change in BA levels and composition was observed after GBP. During the fasted state, BA concentrations were generally reduced at 1 month, but increased 2 years post GBP. Postprandial BA levels were unchanged 1 month post GBP, but an exaggerated postprandial peak was observed 2 years after the surgery. A significant increase in the 12α-hydroxylated/non12α-hydroxylated BA ratio during fasting and postprandially at 2 years, but not 1 month, post GBP was observed. Significant correlations between BAs vs FGF-19, body weight, the incretin effect and peptide YY (PYY) were also found. CONCLUSIONS: This study provides evidence that GBP temporally modifies the concentration and composition of circulating BAs in individuals with T2DM, and suggests that BAs may be linked to the improvement in T2DM after GBP.
INTRODUCTION
Gastric bypass surgery (GBP) results in large, sustained weight loss and significant improvement in obesity-related comorbidities including type 2 diabetes (T2DM); 1,2 however, it is still debated if the improvement in T2DM occurs independently of caloric restriction and weight loss. Bile acids (BAs) are signaling molecules that modulate a number of metabolic processes, including glucose and lipid metabolism 3, 4 and energy expenditure. 5 Several studies have reported that fasted and postprandial circulating BA levels are increased after GBP in cohorts without T2DM or with mixed T2DM status; [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] however, this has not been investigated longitudinally in an exclusively T2DM cohort. Moreover, the relationship between BAs vs body weight, glucose-related parameters and gut hormones is unclear. Thus, there are gaps in understanding the effects of GBP on BA metabolism and its association with obesity and T2DM.
BAs have been linked to glucose metabolism. BAs are ligands for TGR-5 and farnesoid X receptor (FXR), which influence lipid and glucose homeostasis. 16, 17 Activation of TGR-5 has been shown to stimulate the release of the incretin glucagon-like peptide (GLP)-1, 18 and is important for maintaining normoglycemia. 18, 19 BA activation of FXR in the intestine stimulates synthesis of fibroblast growth factor (FGF)-19, 20 a secreted factor that leads to the inhibition of CYP7A1 expression in the liver. 21 FXR activity is important for maintaining normolipidemia, normoglycemia and BA homeostasis. 3, [22] [23] [24] 12α-hydroxylated (12α-OH) BAs in particular associate with insulin resistance in humans 25 and are increased in human 26 and rodent models 27, 28 of diabetes.
We sought to investigate the effect of GBP on circulating BA levels and composition and circulating FGF-19 levels during both the fasted and postprandial states in severely obese individuals with T2DM who experienced significant improvement or remission of T2DM after GBP. We also investigated relationships between BAs vs body weight, glucose metabolism and gut hormones in this population. This study is unique as it focuses exclusively on subjects with T2DM, follows subjects during both an acute (1 month) and chronic time point (2 years), carefully characterizes changes in BA composition, and measures the postprandial response to an oral glucose load. We hypothesized that fasted and postprandial total BAs and FGF-19 levels would increase after GBP, with a reduction in the 12α-OH/non-12α-OH BA ratio. We also hypothesized that a significant relationship between BAs vs FGF-19, body weight, glucose metabolism and gut hormones, would emerge.
MATERIALS AND METHODS
Thirteen obese women with T2DM were studied before, 1 month and 2 years after GBP with a 3-h oral glucose tolerance test (OGTT, 50 g glucose in 200 ml noncarbonated total volume) and an isoglycemic intravenous glucose infusion to calculate the incretin effect on insulin as previously
Statistical analysis
Linear mixed model analysis was used to detect changes in all variables over time relative to surgery. Repeated measures analysis of variance with simple contrasts was used to detect changes: (1) over the time course of the OGTT (fasted vs postprandial); (2) over longitudinal time relative to surgery (that is, pre, 1 month, 2 years); and (3) for the interaction of OGTT time course x longitudinal time for all outcome variables. Paired t-tests were used to calculate change from presurgery at 1 month vs 2 years. Linear mixed model analysis was used to test for omnibus correlations between sets of variables measured longitudinally (for example, body weight measured pre, 1 month and 2 years vs BAs measured at the same time points). R values were estimated for predictors in mixed model analyses based on improvements in log-likelihoods between baseline and more complex models (for example, model containing one or more predictors compared with model with slope only). 31 Data were log-transformed as necessary to correct for skewness. Data are expressed as mean ± s.d. in the tables and mean ± s.e.m. in the figures. Statistical significance was set at Po0.05 (two tailed). SPSS 19.0, 21.0 and 22.0 were used for data analysis.
RESULTS

Clinical characteristics
Subject characteristics are presented in Table 1 . Body weight loss was 11% at 1 month and 31% at 2 years. As expected, glucose levels and insulin sensitivity improved at 1 month and either improved further and/or normalized by 2 years. As shown previously, circulating gut hormone concentrations increased significantly in response to oral glucose after GBP, with an~300% and 50% increase in GLP-1 and PYY area under the curve (AUC), respectively, and an 80% increase in peak GIP ( Table 1 , Supplementary Figure 1 ). No significant change in ghrelin was observed, although levels tended to be higher 2 years after surgery.
Effect of GBP on circulating fasted BA levels and composition
During the fasted state, most circulating individual and nearly all composite BA levels followed the same trend; a small reduction at 1 month, followed by an increase 2 years after GBP (Figure 1 ; Supplementary Table 1 ). However, only the unconjugated BAs reached significance (Figures 1c-e; Supplementary Table 1 ). The change in fasted BA levels was significantly different at 1 month vs 2 years for the composite variables total, primary, secondary, secondary unconjugated and 12α-OH ( Figure 2 ). Figure 3 ). The rise in peak BA levels 30 min after ingestion was more exaggerated 2 years vs 1 month after surgery. We observed a significant difference between the change at 1 month vs 2 years post GBP (at 30 min and from 0 to 60 min AUC after oral glucose) for 12α-OH BAs (P o 0.05) as well as trends for total BAs (P = 0.07), primary BAs (P = 0.08) and secondary BAs (P = 0.08; Figure 3 ; Supplementary Table 2 ). No difference in absolute AUC from 0 to 180 min was observed (Supplementary Table 3 ).
Effect of GBP on ratios of circulating BA levels during fasting and postprandially Computed ratios of the circulating composite BA variables revealed a predominance of primary and conjugated BAs, compared with secondary and unconjugated BAs, respectively (Figures 1g and 4a and b; Supplementary Table 1 ). During fasting and postprandially, there was a trend for the primary/secondary BA ratio to progressively decline after surgery. During fasting, the conjugated/unconjugated ratio appeared relatively unchanged post GBP. However, during the postprandial period, a non-significant spike in the conjugated/unconjugated ratio was evident at 30 min during the post-surgery conditions compared to presurgery (Figure 4b ). During both the fasted and postprandial states, the 12α-OH/non-12α-OH ratio increased significantly at the 2-year time point post surgery relative to presurgery and 1 month post surgery (Po 0.05; Figure 1g and Figure 4c ).
Effects of GBP on circulating FGF-19 levels and correlation between BAs and FGF-19
FGF-19 levels were significantly increased in the postprandial state, compared with fasted levels (P o 0.05; Supplementary  Figure 2a ). Although there appeared to be a progressive increase in FGF-19 fasted, peak and AUC levels from presurgery to 2 years post surgery, these did not reach significance ( Supplementary  Figure 2a,b) . We also observed a striking correlation between total BA AUC and FGF-19 AUC (P o 0.001; Supplementary Figure 2c ).
Correlations between BAs and body weight, glucose-related parameters and gut hormones Body weight, but not weight loss, was negatively correlated with both total BAs (r = 0.345, P = 0.049) and secondary BAs (r = 0.303, P = 0.024) during fasting. The incretin effect on insulin was positively correlated with the AUC of total BAs (r = 0.265, P = 0.032), primary BAs (r = 0.304, P = 0.017), conjugated BAs (r = 0.304, P = 0.031), 12α-OH BAs (r = 0.253, P = 0.032) and non12α-OH BAs (r = 0.251, P = 0.04). However, fasted and postprandial glucose and insulin, and insulin sensitivity (HOMA-IR, ISI) were not significantly correlated with BAs. PYY AUC was positively correlated with the AUC of primary BAs (r = 0.343, P = 0.04), unconjugated BAs (r = 0.482, P = 0.004) and non12α-OH BAs (r = 0.364, P = 0.04). There appeared to be a trend for GIP and GLP-1 AUC to correlate with BA composite variables, but none of these reached significance (data not shown).
DISCUSSION
It remains unclear whether the mechanisms independent of weight loss have a role in the remarkable improvement in T2DM after GBP. Altered BA metabolism has been linked to T2DM, 16 and it has been suggested that changes in BA metabolism after GBP could mediate improvements in T2DM.
In our cohort of subjects with T2DM, we observed a temporal pattern of change in BA levels and composition during both the fasted and postprandial states. We found a reduction or no Bile acids after gastric bypass in type 2 diabetes change at 1 month and increase at 2 years, for most BA composite variables and the 12α-OH/non12α-OH BA ratio. We also identified significant relationships between BAs vs FGF-19, body weight, the incretin effect on insulin, and PYY.
Our study confirms that the temporal change in fasted and postprandial total BAs after GBP, documented in obese populations without T2DM, 13, 14 also occurs in a population with T2DM. Total BAs do not rise immediately after GBP (4-7 days), 7, 13, 14 and it is not entirely clear when this increase begins. Some studies report a significant increase in total BAs 1-3 months post GBP, 7, 14, 15 whereas other studies (including ours) do not. 13 Although most studies show a general increase in BAs long term after GBP, 6, [8] [9] [10] [11] [12] [13] [14] the pattern of change in BA composition after GBP is unclear. Some studies have observed that the postprandial increase in BAs is driven by conjugated BAs, 10,14 but others did not observe this effect. 8, 10, 12 We observed a non-significant spike in the conjugated/unconjugated ratio 30 min after glucose ingestion at both timepoints after GBP. Moreover, this observed increase has been reported to be due to the glycine-conjugated BAs, 10, 14 and the taurine/glycine ratio during fasting is lower after GBP. 8 Primary BAs (CDCA, CA) are synthesized and conjugated in the liver. After export to the small intestine, these primary BAs are deconjugated and dehydroxylated by gut microbiota to secondary BAs (DCA, LCA). 20 Thus, it is tempting to speculate that altered gut microbiota abundance and diversity, which has been reported after GBP, [32] [33] [34] [35] could have a role in the shift in BA composition.
In our study, the most striking change in BA composition after GBP was with respect to the 12α-OH/non12α-OH ratio. This ratio is predominately determined by the expression of Cyp8b1 in the liver, responsible for the synthesis of CA and its derivatives. Contrary to our hypothesis, we observed a significant and preferential increase in the 12α-OH/non12α-OH ratio 2 years after GBP. These findings were somewhat unexpected, considering that 12α-OH BAs are reported to be higher in human and rodent models of insulin resistance and T2DM [25] [26] [27] [28] and that the genetic deletion of Cyp8b1 in mice leads to improved insulin secretion and glucose tolerance. 36 In addition, caloric restriction has been shown to increase 12α-OH BAs in a rodent model, 37 and caloric restriction would be expected to be more stringent at 1 month, compared with 2 years, after surgery.
The relationship between BAs, obesity and T2DM is complex. Total BAs are reported to be blunted in obese persons compared with lean controls during fasting and/or postprandially. 13, 14, 38 This blunting appears to be driven by conjugated BAs, specifically, glycine-conjugated BAs. 14, 38 T2DM is associated with altered BA metabolism. 9, 25, 39, 40 Total BAs in obese persons with T2DM are reported to be higher compared with normoglycemic obese controls during fasting and postprandially; 9,39,40 some studies showed that this was driven by an increase in either glycine and/ or taurine-conjugated BAs. 39, 40 Another study showed that plasma CA and CDCA were inversely associated with insulin sensitivity. 41 The increase in BAs after GBP is unlikely to be secondary to glycemic control, as a recent report showed that intensive glycemic control with insulin did not affect circulating BA levels or composition. 40 Recently, total urinary BA excretion has been shown to be significantly greater in subjects with T2DM compared with lean subjects without T2DM. 42 Interestingly, stratification based on BMI showed that this was driven by lean and overweight subjects with T2DM, and not evident in obese subjects with T2DM, suggesting that the obese state and T2DM have independent and potentially opposing effects on BA metabolism. 42 Blunted total BA levels in obese subjects are increased 10-12 months post GBP. 13, 14 Ahmad et al. 14 found that this effect appeared to be due to an increase in glycine-conjugated BAs, and was more pronounced in the postprandial, rather than the fasted state. Weight loss has been speculated as a mechanism for the altered BA response after GBP; however, evidence for this is unclear. Kohli et al. 12 observed that after 20% weight loss, fasted and postprandial total BA levels were significantly higher post GBP, but lower after gastric banding. Steinert et al. 13 showed that GBP and vertical sleeve gastrectomy increased circulating fasted total BA levels similarly, but only GBP significantly increased postprandial BA levels. On the other hand, we observed a negative relationship between body weight vs total BAs, similar to what was reported by Steinert et al. 13 Future studies should clarify the role of weight and weight loss to changes in BA metabolism.
FGF-19 has an important role in the regulation of BA synthesis in humans 43 and has been linked to improvements in lipid and glucose metabolism 44, 45 and the regulation of food intake. 46 A recent study in mice with genetic manipulation of FXR activity showed that this target is critical for the reduction in body weight, food intake, and improvement in glucose control after vertical sleeve gastrectomy. 47 Two studies have observed an increase in fasted FGF-19 levels early (days-3 months) 7,15 after GBP in humans; however, Patti et al. 6 did not observe this in post-GBP subjects compared with morbidly obese or overweight controls. Moreover, Pournaras et al. 7 observed that this effect was found exclusively after GBP and not after AGB. Gerhard et al. 9 observed that fasted FGF-19 levels were significantly lower in subjects with T2DM compared with subjects without T2DM, and that FGF-19 levels were increased to a greater degree after GBP in subjects that underwent T2DM remission compared with subjects without T2DM or who did not undergo remission. We did not observe any significant increase in FGF-19 levels after GBP. Yet, we observed a strong, positive correlation between postprandial total BAs vs FGF-19. This may be regarded as surprising, as the net effect of FGF-19 activation of FGF receptor-4 is to downregulate BA synthesis. 20 However, these increased FGF-19 levels could reflect a response to increased circulating BA levels, as BAs bind to FXR and stimulate FGF-19 synthesis. 20 This correlation, although supportive of a role for FGF-19 in human BA physiology, prompts further investigation of this relationship in humans.
BAs stimulate GLP-1 and PYY secretion via the activation of the TGR-5 receptor 18,48-51 on enteroendocrine L-cells. 52 Previous studies including post-GBP subjects reported a relationship between peak GLP-1 levels and total BAs 6,12 and another study in healthy individuals reported correlations between specific BAs and GLP-1 and PYY. 53 Yet, a relationship between total BAs and GLP-1 was not observed in Steinert et al., 13 and was not significant in our study either. However, we did observe a positive relationship between PYY vs multiple BA composite variables during the postprandial state. In humans, vertical sleeve gastrectomy enhances postprandial GLP-1 and PYY release as well, without any increase in circulating postprandial BAs. 13 In addition, the fact that the rise in PYY and GLP-1 shortly after the surgery ( o1 week) does not parallel the rise in BAs which is much later, 13 suggests that the link between BAs and gut hormones is still murky. Future studies are required to clarify the contribution of increased BA levels to GLP-1 and PYY release.
GBP leads to several anatomic changes to the gastrointestinal tract, which could alter BA metabolism. The distal mixing of undigested nutrients with gallbladder and pancreatic excretions in lower sections of the jejunum, the change in pH, and accelerated nutrient transit time, all may all alter BAs. [54] [55] [56] [57] Furthermore, gut hypertrophy 58 could potentially alter the site or efficiency of BA reabsorption. Another potentially attractive hypothesis is that changes in the gut microbiome, reported after GBP, [33] [34] [35] modulate BA metabolism, as the gut microbiota have a key role in BA deconjugation, dehydroxylation and dehydrogenation. 59 There are also numerous other potential contributors to changes in BA levels after GBP, including alterations in hepatic insulin sensitivity, BA synthesis or excretion, enterohepatic cycling and gut permeability. Clearly, circulating BAs are a complex variable reflecting a number of processes-synthesis, excretion, trafficking-that may each be modulated differentially by GBP.
There are several limitations to this study. First, our sample size was small, and BAs, particularly in the postprandial state, were highly variable, as also shown by others. 60, 61 Several factors may contribute to this variability including surgical technique, T2DM status, 9 timing of sampling in relation to surgery, energy balance status, 13, 14 insulin sensitivity, 27 diet composition, and others. Second, our population was exclusively women, which could limit interpretation of the data, as gender differences in BA metabolism have been reported. 62 In addition, in this study, 3/13 subjects underwent a cholecystectomy, two were before surgery and one occurred 2 months after surgery. As this may alter BA kinetics or composition, [63] [64] [65] [66] we analyzed the data during the fasted state, excluding these three subjects, and observed very similar results (data not shown). Moreover, our measurements were limited to peripheral blood concentrations of BAs. Although portal blood concentrations have been shown to correlate with peripheral values, 67 measurements of BA synthesis would be more telling. Finally, we used an OGTT, rather than a mixed meal test, which although providing a unique perspective, may not be the most appropriate representation of BA response in a human GBP model.
This study provides a significant and unique contribution to the literature. It is the only study to report the effects of GBP on fasted and postprandial BA levels in individuals with T2DM, up to 2 years after surgery, and the only to measure BA response to an oral glucose load in a GBP population. We observed a general reduction or no change in BA levels or composition 1 month post GBP, but an overall increase in BAs and the 12α-OH/non12α-OH ratio 2 years after surgery. BAs appeared to be related to FGF-19, body weight, the incretin effect on insulin, and PYY. Further work is necessary to understand the etiology and implications of the temporal change in circulating BA levels after GBP in subjects with T2DM.
